Insulet
PODD
788 hedge funds and large institutions have $14.6B invested in Insulet in 2026 Q1 according to their latest regulatory filings, with 87 funds opening new positions, 327 increasing their positions, 269 reducing their positions, and 123 closing their positions.
144% more call options, than puts
Call options by funds: $35.7M | Put options by funds: $14.7M
22% more repeat investments, than reductions
Existing positions increased: 327 | Existing positions reduced: 269
1.14% less ownership
Funds ownership: 100.01% → 98.88% (-1.1%)
6% less funds holding
Funds holding: 834 → 788 (-46)
27% less capital invested
Capital invested by funds: $20B → $14.6B (-$5.39B)
29% less first-time investments, than exits
New positions opened: 87 | Existing positions closed: 123
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$456M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$286M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$254M |
| 4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$119M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$104M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$688M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$591M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$96.7M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$96.5M |
| 5 |
RI
RTW Investments
New York
|
-$92.3M |
PODD Hedge Fund Activity: Q1 2026 in Review
788 of the 8,208 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q1 2026, worth a combined $14.6B — down 27% from $20B a quarter earlier.
Sellers outnumbered buyers: 123 funds closed out of PODD and 87 opened new positions — a net loss of 36 holders — while 269 trimmed existing stakes and 327 added.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $456M. The largest seller was Capital Research Global Investors, cutting an estimated $688M.
- 788 institutional investors held Insulet (PODD) as of Q1 2026, down from 834 in Q4 2025.
- Funds reported $14.6B of Insulet stock for Q1 2026, down 27% quarter-over-quarter.
- 87 funds opened new Insulet positions in Q1 2026 and 123 closed out, a net change of -36 holders.
- The largest Insulet buyer in Q1 2026 was T. Rowe Price Investment Management, an estimated $456M added.
- The largest Insulet seller in Q1 2026 was Capital Research Global Investors, an estimated $688M sold.
Based on aggregated 13F filings for Q1 2026.